No black box warning on record for Idhifa

As of the latest FDA labeling reviewed, Idhifa (ENASIDENIB MESYLATE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Idhifa medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Embryo-Fetal Toxicity : IDHIFA can cause fetal harm. Advise patients of the potential risk to a fetus and use effective contraception ( 5.2 , 8.1 , 8.3 ). 5.1 Differentiation Syndrome In the clinical trial, 14% of patients treated with IDHIFA experienced differentiation syndrome, which may be life-threatening or fatal if not treated. Differentiation syndrome is associate

No black box warning on record for Idhifa

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS Embryo-Fetal Toxicity : IDHIFA can cause fetal harm. Advise patients of the potential risk to a fetus and use effective contraception ( 5.2 , 8.1 , 8.3 ). 5.1 Differentiation Syndrome In the clinical trial, 14% of patients treated with IDHIFA experienced differentiation syndrome, which may be life-threatening or fatal if not treated. Differentiation syndrome is associate

Idhifa Black Box Warning

No black box warning on record for Idhifa

Other warnings & precautions

Idhifa Black Box Warning

No black box warning on record for Idhifa

Other warnings & precautions